Mirnas and Their Potential For Use Against Cancer and Other Diseases
- 10 October 2007
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 3 (5) , 521-537
Abstract
MiRNAs are 19-24 nucleotide long noncoding RNAs found in almost all genetically dissected species, including viruses, plants, nematodes, flies, fish, mice and humans. Rapid advances have been made in understanding their physiological functions, while abnormal patterns of miRNA expression have been found in many disease states, most notably human cancer. It is now clear that miRNAs represent a class of genes with a great potential for use in diagnosis, prognosis and therapy. In this review we will focus on the discoveries that elucidate their crucial role in mammalian diseases, particularly in cancer, and propose that miRNA-based gene therapy might become the potential technology of choice in a wide range of human diseases including cancer.Keywords
This publication has 135 references indexed in Scilit:
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- A pancreatic islet-specific microRNA regulates insulin secretionNature, 2004
- The Microprocessor complex mediates the genesis of microRNAsNature, 2004
- Processing of primary microRNAs by the Microprocessor complexNature, 2004
- The functions of animal microRNAsNature, 2004
- The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNACell, 1997